All In Biotech

Free tool

Medicare drug spending

CMS's Spending by Drug data: what Medicare paid for each drug before manufacturer rebates. Part D covers drugs dispensed by pharmacies; Part B covers drugs given in a doctor's office or hospital outpatient department. Commercial and list prices are not public data and are not shown.

Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations

Part D, 2024

$288.7B

Gross drug spending in the dataset

Part B, 2024

$60.8B

Gross drug spending in the dataset

Drugs listed

10

Part D and Part B

Total spending by year

  • Part D
  • Part B
View as table
YearPart DPart B
2020$194,092,038,339$37,778,829,680
2021$213,513,349,361$40,135,340,775
2022$239,779,215,689$44,241,259,745
2023$275,808,918,753$50,775,853,083
2024$288,667,842,058$60,838,164,403
Reset

Top 10 by total spending

2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.

DrugPartSpendingChangeBeneficiariesPer beneficiaryPer unit
Metronidazole*

Metronidazole

D$56.4M-20%1,629,321$35$0.59
Noritate

Metronidazole

D$3.3M+8%1,090$2,990$31.90
Bismuth-Metronidazole-Tetracyc

Bismuth/Metronid/Tetracycline

D$2.6M+40%4,359$594$4.44
Vandazole

Metronidazole

D$215K-20%2,418$89$0.94
Nuvessa

Metronidazole

D$130K+18%439$295$40.25
Metronidazole

Metronidazole/Sodium Chloride

D$64K-13%1,192$54$0.02
Metrogel

Metronidazole

D$40K-73%60$671$5.94
Metro IV*

Metronidazole/Sodium Chloride* · J1836

B$29K+8248%16,987$2$0.03
Metro IV

Metronidazole/Sodium Chloride

D$2K-50%25$72$0.03
Flagyl

Metronidazole

D$994n/an/an/a$6.45

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.